Speaker: Icro Meattini

0:01:11

MBN2021 with Icro Meattini

0:01:36

EUROPA: radiotherapy versus endocrine therapy in low-risk early breast cancer

0:02:11

Partial and no radiation in elderly patients with breast cancer

0:00:50

Patient-friendly radiation courses in breast cancer

0:00:46

Debating radiation therapy after pathological complete response in breast cancer

0:00:40

Innovations in radiation therapy planning

0:02:34

Is cardiac damage still relevant? How can it be avoided?

0:01:52

Role of RT in early breast cancer

0:00:58

FAST-Forward: safety of ultra-hypofractionated radiotherapy on cardiac health

0:00:41

Long-term evidence for partial breast irradiation in early breast cancer

0:01:47

SAFE: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab

0:00:54

De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer

0:01:34

Cardiac toxicity in patients with breast cancer

0:01:57

Cardioprotective strategies in the management of breast cancer

0:00:48

Evaluating the safety of T-DXd with radiotherapy in HER2+ metastatic breast cancer

0:00:52

De-escalation of axillary radiotherapy in early breast cancer

0:01:01

De-escalating treatment in patients with breast cancer post-surgery

0:01:24

EUROPA: endocrine therapy or partial breast irradiation for older women with breast cancer

0:01:36

Intensive follow up for patients with high-risk breast cancer

0:03:22

Impact of metastases-directed radiation therapy on CDK4/6 inhibitors treatment for mBC

0:04:47

Breast reconstruction and radiation therapy consensus from AIRO

0:01:33

ROCK: preoperative robotic radiosurgery for early breast cancer

0:00:58

The treatment of BC brain metastases

0:03:26

Subgroup analysis from SAFE trial: pharmacological cardioprotective strategies for breast cancer